Helicobacter Pylori infection and eradication therapy of our out patients in 2005 and 2010 years. What has been changed with time?

Incidence of Helicobacter pylori (HP) infection decreased in Europe and in the US as well. This achievement may be attributed to the diagnostic and therapeutic efforts. The success rate of the attempt of HP eradication with first line therapy decreased from 80–90% to 75–80%. The resistance of HP to antimicrobial agents particularly to metronidazole and clarithromycin is an important factor affecting the outcome of standard treatment for HP eradication. Aim: To study the incidence of HPinfection among our outpatients and to evaluate the success rate of separate eradication treatment compared the data of 2005 and…